Market Cap (In CNY)
18.67 Billion
Revenue (In CNY)
49.72 Billion
Net Income (In CNY)
-651.75 Million
Avg. Volume
135.08 Million
- Currency
- CNY
- Country
- Financial Services
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.61-5.42
- PE
- -25.53
- EPS
- -0.15
- Beta Value
- 0.724
- ISIN
- CNE000000F48
- CUSIP
- -
- CIK
- -
- Shares
- 4876796406.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Financial Services
- Industry
- Insurance - Life
- CEO
- Ms. Wenxia Zhou
- Employee Count
- -
- Website
- https://www.biocause.com
- Ipo Date
- 1996-11-12
- Details
- Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.
More Stocks
-
IMAS
-
1709
-
5214
-
0A1KNIO Inc.
0A1K
-
APGNAPG|SGA SA
APGN
-
TGGI
-
ROGRoche Holding AG
ROG
-
6874